(Q48422105)

11 February 2018

title

Serotonin dysfunction in pathological gamblers: increased prolactin response to oral m-CPP versus placebo. (English)

1 reference

11 February 2018

0 references

1 reference

5

Eric Hollander

1 reference

11 February 2018

author name string

Stefano Pallanti

1

1 reference

11 February 2018

Silvia Bernardi

2

1 reference

11 February 2018

Leonardo Quercioli

3

1 reference

11 February 2018

Concetta DeCaria

4

1 reference

11 February 2018

publication date

1 December 2006

1 reference

11 February 2018

published in

C N S Spectrums

1 reference

11 February 2018

volume

11

1 reference

11 February 2018

issue

12

1 reference

11 February 2018

page(s)

956-964

1 reference

11 February 2018

Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

Sexually dimorphic relationship of a 5-HT2A promoter polymorphism with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

'Behavioral' addictions: do they exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

Pindolol pretreatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal men

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

Specificity of ethanollike effects elicited by serotonergic and noradrenergic mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

Euphorogenic properties of the serotonergic partial agonist m-chlorophenylpiperazine in cocaine addicts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

Serotonergic stimulation of pituitary-adrenocortical function in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

Serotonergic responsivity in trichotillomania: neuroendrocrine effects of m-chlorophenylpiperazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

Pharmacokinetics of m-chlorophenylpiperazine after intravenous and oral administration in healthy male volunteers: implication for the pharmacodynamic profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

Serotonergic stimulation of prolactin and corticosterone secretion is mediated by different pathways from the mediobasal hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

The meta-chlorophenylpiperazine challenge test in cocaine addicts: hormonal and psychological responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

The neurobiology of pathological gambling

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

Is there a common molecular pathway for addiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

Pathological gambling caused by drugs used to treat Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

Should the scope of addictive behaviors be broadened to include pathological gambling?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

Serotonergic Function in Obsessive-Compulsive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

The subjective effects of MDMA and mCPP in moderate MDMA users

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

Methylone and mCPP, two new drugs of abuse?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

Neuroscience of addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

7 January 2021

Effect of serotonin-releasing drugs on serum corticosterone concentration in rats

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

7 January 2021

Pharmacological challenge with a serotonin 1D agonist in alcohol dependence

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

7 January 2021

Serotonergic sensitivity in borderline personality disorder: preliminary findings.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

7 January 2021

A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

7 January 2021

Should addictive disorders include non-substance-related conditions?

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

7 January 2021

Ethanollike properties of the serotonergic partial agonist m-chlorophenylpiperazine in chronic alcoholic patients

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015145

7 January 2021

10.1017/S1092852900015145

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

17146409

1 reference

11 February 2018